This implies that ATRX losses, which lead to an alternative lengthening of telomeres, may not be sufficient on their own to drive tumor formation but may complement mutant IDH1 expression, suggesting their potential functional synergism [34]. This evidence concerns the gene ATRX and neoplasm.